2010 projected leaders: First baseman OPS

0 Comments

Over the next several days, I’ll be dipping into my 2010 projections and presenting some leaderboards.
1. Albert Pujols – 1067
2. Prince Fielder – 976
3. Miguel Cabrera – 965
4. Mark Teixeira – 962
5. Adrian Gonzalez – 933
6. Ryan Howard – 923
7. Lance Berkman – 911
8. Kevin Youkilis – 898
9. Kendry Morales – 889
10. Justin Morneau – 884
11. Adam Dunn – 882
12. Joey Votto – 882
13. Todd Helton – 874
14. Billy Butler – 872
15. Derrek Lee – 871
– I don’t suppose there are any surprising names here. Everyone in the group besides Butler came in at 870 or better last year, and Butler finished at 853. The other two players I have projected for modest gains are Cabrera (942 to 965) and Teixeira (948 to 962). On the other side of the equation, I have Votto and Lee projected for 100-point declines, but that still doesn’t knock either off the list.
– First base is such a strong position right now. The first four players here received my four highest OPS projections for the year, followed by Joe Mauer at 958.
– I’m not going to run down the entire list of DHs, but Vladimir Guerrero topped that one at 879, followed by David Ortiz at 862 and Jim Thome at 851.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.